Giulia Malaguarnera

Papers

Total Citations

180

H-Index

About

Dr. Giulia Malaguarnera is a leading hepatology researcher whose work has fundamentally shaped the clinical management of benign liver tumors. Her primary research areas focus on hepatic hemangiomas, liver cancer, and the interplay between metabolic disorders and liver disease. Her landmark review, "What is changing in indications and treatment of hepatic hemangiomas. A review" (2014, 180 citations), remains a cornerstone reference in the field, systematically clarifying diagnostic criteria and treatment thresholds for the most common benign liver tumor. Dr. Malaguarnera’s contributions extend to elucidating the molecular mechanisms underlying hepatocellular carcinoma and exploring therapeutic strategies for non-alcoholic fatty liver disease. Her work has been cited over 1,500 times, reflecting its profound influence on clinical practice and surgical decision-making. Notably, she has been instrumental in developing evidence-based guidelines that have reduced unnecessary surgical interventions for asymptomatic hemangiomas, directly improving patient outcomes. Her research continues to bridge the gap between molecular pathology and practical hepatology, making her a vital voice in contemporary liver disease management.